Katie Campbell, PhD Parker Bridge Fellow (in partnership with the V Foundation for Cancer Research) Biography Katie Campbell, PhD, joined the laboratory of Antoni Ribas, MD, PhD, at the University of California, Los Angeles as a postdoctoral researcher in 2018, initially focusing on establishing cloud-based computational pipelines to automate and parallelize the processing of genomics and transcriptomics data derived from clinical melanoma tumor biopsies and patient-derived melanoma models. She has since expanded these approaches to integrate multiplexed spatial profiling data to understand the complex molecular drivers and cellular interactions responsible for immunotherapeutic response in melanoma clinical specimens. Katie’s current research aims to understand how the somatic alterations in the antigen presentation machinery modulate tumor-T-cell interactions, particularly through copy number alterations that result in imbalance or loss of human leukocyte antigen (HLA) genes. Her interests and approaches collectively enable the comprehensive molecular profiling of tumors, defined by interface of tumor drivers and immunogenicity, to improve immunotherapeutic strategies. She is a 2022 Parker Bridge Fellow and a postdoctoral fellow at UCLA, where she uses genomics technologies to analyze immunotherapies and the treatment of melanoma. Katie earned her undergraduate degree in biochemistry at the Penn State University and earned her PhD in molecular cell biology at Washington University in St. Louis. Education & Training 2018: Washington University in St. Louis, PhD, Molecular Cell Biology 2014: Penn State University, BS, Biochemistry and Molecular Biology Awards & Honors 2022: Parker Bridge Fellow 2021-22: The V Foundation-Gil Nickel Endowed Fellowship in Melanoma Research 2020-22: Irvington Postdoctoral Fellowship, Cancer Research Institute 2021: Cancer Immunology Scholar, Arthur L. Irving Family Foundation 2018-present: Postdoctoral Fellow, UCLA